Cyclophosphamide versus Placebo in Scleroderma Lung Disease
2006 · New England Journal of Medicine · 1,635 citations
https://doi.org/10.1056/nejmoa055120
J
John Varga
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
456
Papers
32.8K
Citations
94
h-index
275
i10-index
John Varga is an academic researcher from Northwestern University. The author has contributed to research in topics: Systemic Sclerosis and Related Diseases & Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis & Dermatologic Treatments and Research. The author has an h-index of 94, co-authored 388 publications.
ORCID: 0000-0001-8400-687XPapers by this author
worksMycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
2016 · The Lancet Respiratory Medicine · 1,028 citations
https://doi.org/10.1016/s2213-2600(16)30152-7
Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management
2010 · Arthritis Research & Therapy · 176 citations
https://doi.org/10.1186/ar3097
Impact of oral cyclophosphamide on health‐related quality of life in patients with active scleroderma lung disease: Results from the scleroderma lung study
2007 · Arthritis & Rheumatism · 96 citations
https://doi.org/10.1002/art.22580
Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker?
2012 · Arthritis Research & Therapy · 96 citations
https://doi.org/10.1186/ar3827
Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort
2021 · Arthritis Research & Therapy · 65 citations
https://doi.org/10.1186/s13075-021-02548-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat